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Abstract
Background: Nicotinic acetylcholine receptors (nAChR) have been identified on a variety of cells of the immune
system and are generally considered to trigger anti-inflammatory events. In the present study, we determine the
nAChR inventory of rat alveolar macrophages (AM), and investigate the cellular events evoked by stimulation with
nicotine.
Methods: Rat AM were isolated freshly by bronchoalveolar lavage. The expression of nAChR subunits was analyzed
by RT-PCR, immunohistochemistry, and Western blotting. To evaluate function of nAChR subunits,
electrophysiological recordings and measurements of intracellular calcium concentration ([Ca2+]i) were conducted.
Results: Positive RT-PCR results were obtained for nAChR subunits a3, a5, a9, a10, b1, and b2, with most stable
expression being noted for subunits a9, a10, b1, and b2. Notably, mRNA coding for subunit a7 which is proposed
to convey the nicotinic anti-inflammatory response of macrophages from other sources than the lung was not
detected. RT-PCR data were supported by immunohistochemistry on AM isolated by lavage, as well as in lung
tissue sections and by Western blotting. Neither whole-cell patch clamp recordings nor measurements of [Ca2+]i
revealed changes in membrane current in response to ACh and in [Ca2+]i in response to nicotine, respectively.
However, nicotine (100 μM), given 2 min prior to ATP, significantly reduced the ATP-induced rise in [Ca2+]i by 30%.
This effect was blocked by a-bungarotoxin and did not depend on the presence of extracellular calcium.
Conclusions: Rat AM are equipped with modulatory nAChR with properties distinct from ionotropic nAChR
mediating synaptic transmission in the nervous system. Their stimulation with nicotine dampens ATP-induced Ca2+-
release from intracellular stores. Thus, the present study identifies the first acute receptor-mediated nicotinic effect
on AM with anti-inflammatory potential.
Background
Alveolar macrophages (AM) hold a key position in initi-
ating pulmonary inflammatory responses by secreting
tumor necrosis factor a (TNFa) and several additional
cytokines and chemokines. It has been demonstrated
that TNFa production and release from peritoneal
macrophages can be largely inhibited by neurally
released ACh thereby attenuating systemic inflammatory
responses. This physiological mechanism has been
termed “cholinergic anti-inflammatory pathway” [1].
Studies on monocyte-derived human macrophages and
on nicotinic acetylcholine receptor (nAChR) deficient
mouse strains revealed that the nAChR a7 subunit is
essential for this anti-inflammatory pathway [2]. It has
been demonstrated that stimulation of mouse peritoneal
macrophages with nicotine is associated with activation
of the Jak2-STAT3 signaling pathway and with inhibi-
tion of the release of pro-inflammatory cytokines and
chemokines [3]. Several lines of evidence show that sti-
mulation of the cholinergic anti-inflammatory pathway
and application of nicotinic agonists can be beneficial in
experimental endotoxemia and sepsis [1-3]. The a7
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subunit is one of 9 different known ligand-binding a
subunits (a1-a7 and a9-a10) that assemble to homo-
or heteropentamers, partially with additional participa-
tion of b subunits, to form a functional nAChR. All
these receptors are ligand-gated cation channels, and
they are distinct from each other with respect to ligand
affinity and to preference for mono- or divalent cations
[4]. There is growing evidence that neuronal-type ion
channels are not formed by nAChR subunits in cells of
the immune system [5-7].
In view of the natural occurrence of nAChR ligands in
the alveolar compartment (e.g. choline) and of the clini-
cal relevance of nicotine contained within cigarette
smoke, the potential presence of a cholinergic
anti-inflammatory pathway in the lung deserves high
attention. Indeed, nAChR agonists reduce acid- and
gram-negative sepsis-induced acute lung injury in mice
and rats [8,9] and tumour necrosis factor-a (TNF-a)
release into the lung compartment after intrapulmonary
delivery of LPS in mice [10]. Here, we hypothesized that
cholinergic anti-inflammation is operative through mod-
ulation of AM function. We established an inventory of
nAChR subunit expression in rat AM by RT-PCR and
immunohistochemistry. Whole-cell patch-clamp mea-
surements were conducted to investigate whether classi-
cal, ion-conducting nAChR are operative in AM. The
effect of nicotine upon macrophage stimulation with
ATP, a “host tissue damage” or “danger signal” [11], was
investigated by the method of real-time imaging for
cytosolic Ca2+ responses. We demonstrate that there is
a nicotinic anti-inflammatory pathway operative in rat
AM. The receptor subtypes involved and intracellular
signaling pathways, as identified so far, differ from that
known from the nervous system. Potentially, this allows
for selective pharmacological intervention and therapeu-
tic use.
Methods
Alveolar macrophage isolation
Female Wistar rats (8-10 weeks old) were obtained from
the local animal breeding facility (Institute of Physiology,
Justus-Liebig-University, Giessen, Germany) and kept
under conventional conditions. Wild type C57BL6N spe-
cific-pathogen free (SPF) mice were purchased from
Charles River (Sulzfeld, Germany). Mice deficient for
the a7 nAChR subunit were obtained from Jackson
Laboratory (Bar Harbor, USA) and bred in SPF condi-
tions by the local animal breeding facility using hetero-
zygotes as breeders. Male and female mice were used
throughout the study between 8 and 12 weeks of age.
All animals were kept with free access to food and
water. Animal care and animal experiments were per-
formed following the current version of the German
Law on the Protection of Animals as well as the NIH
“principles of laboratory animal care”.
Animals were killed by inhalation of an overdose of
isoflurane (Abbott, Wiesbaden, Germany). For isolation
of rat AM, the lung was carefully removed, cannulated
via the trachea, and bronchoalveolar lavage (BAL) was
performed using 10 × 5 ml ice-cold PBS containing (in
mM): KCl 2.68, KH2PO4 1.47, NaCl 136.89, Na2HPO4
8.10 (pH 7.3) (PAA, Pasching, Austria). Mouse AM
were isolated according to previously described proto-
cols [12]. The lavage fluid was centrifuged at 400 × g
for 5 min at 4°C, and the pellet was resuspended in PBS
or DMEM/F12 GlutaMax-I medium (Invitrogen, Karls-
ruhe, Germany). BAL cells were monitored by micro-
scopy, and preparations containing erythrocytes were
discarded. Isolated macrophages were used for subse-
quent analysis by RT-PCR, immunocytochemistry, Wes-
tern blotting, electrophysiological recordings and
measurements of intracellular calcium concentration
([Ca2+]i).
RT-PCR
Total RNA was isolated from BAL cells (n = 7 rats and
n = 5 C57BL6N mice) using RNeasy Mini Kit (Qiagen,
Hilden, Germany). Genomic DNA contaminations were
removed by DNase I digestion for 15 min at 37°C, 1 U/
reaction (Invitrogen). cDNA synthesis was performed
with iScript (Bio-Rad, Munich, Germany) or SuperScript
II (Invitrogen) kits using 1 μg total RNA. The cDNAs
were amplified with the subunit specific primer pairs
spanning at least one intron (Table. 1 and 2). Hypox-
anthine guanine phosphoribosyl transferase 1 (HPRT1)
and b-microglobulin primers were used to monitor
cDNA integrity for rat and mouse samples, respectively.
For amplification, 2.5 μl buffer II (100 mM Tris-HCl,
500 mM KCl, pH 8.3), 2 μl 15 mM MgCl2, 0.6 μl dNTP
(10 mM each), 0.6 μl of each primer (10 μM), and 0.125
μl AmpliTaq Gold polymerase (5 U/μl, Applied Biosys-
tems, Foster City, USA) were added to 1 μl of cDNA,
and made up to a final volume of 25 μl with H2O.
Cycling conditions were 10 min at 95°C, 40 cycles with
20 s at 94°C, 20 s at 60°C, 20 s at 72°C, and a final
extension at 72°C for 7 min. PCR products were sepa-
rated by electrophoresis on a 1.5% agarose gel in Tris-
acetate-EDTA buffer. Sequencing of PCR products was
done by MWG Biotech (Ebersbach, Germany). Positive
controls for primers detecting rat subunits a1 and b1
were done using reversely transcribed total RNA from
rat muscle tissue. Rat lung was used as a positive con-
trol for subunits b2-b4. For other rat primer pairs, rat
DRG were used as a positive control. Mouse lung was
used as a positive control for all primers detecting
mouse nAChR subunits. Negative controls were
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performed by omitting the reverse transcription step or
using water instead of cDNA template.
Differences were noted for two methods used to pre-
pare cDNA. Successful detection of rat a9 subunit
mRNA required reverse transcription with Superscript II
system. Amplification of rat a9 subunit mRNA from
BAL cDNA generated with iScript enzyme was not suc-
cessful. This may be due to different priming strategies
(oligo(dT) and blend of oligo(dT) + random hexamer
primers, respectively) or to reduced RNAse H activity in
SuperScriptII enzyme, which enables more efficient
cDNA synthesis [13].
Immunofluorescence
Lavaged rat cells (n = 10 animals) were plated on poly-
styrene 8-well culture slides (BD Biosciences, Erembode-
gem, Belgium) in DMEM/F12 supplemented with
penicillin (100 U/ml) and streptomycin (0.1 mg/ml).
Cells were allowed to attach for 2 h, and then fixed in
acetone (-20°C, 10 min) or isopropanol (+4°C, 10 min)
and air-dried for 1 h.
Shock-frozen rat lung specimens were prepared as
described previously [14]. Cryostat sections were cut at
10 μm thickness, fixed as above and subjected to indir-
ect immunofluorescence using antisera directed against
nAChR subunits and monoclonal antibody ED1, direc-
ted to a CD68-like antigen expressed by rat AM [15]
(Serotec, Düsseldorf, Germany) (Table. 3). Briefly,
unspecific binding sites were saturated with 50% normal
horse serum in PBS for 1 h, followed by overnight incu-
bation with the primary antibody, washing (3 × 10 min)
Table 1 Rat primer sequences used in the study
Target Sequence Length Accession No.
nAChR
a1
for. AGCTCACCGCTGTCCTCCT 171 bp [GenBank:
NM_024485]
rev. GGATCAGTTGCAGTCCCACA
nAChR
a2
for. CGCGTCCCTTCAGAGATGAT 114 bp [GenBank:
L31622]
rev. CACAGTGCCCGTGAAGAA
nAChR
a3
for. CCTCCCTGTCTATCGGGTCT 161 bp [GenBank:
X03440]
rev. GCCGGATGATCTCGTTGTAA
nAChR
a4
for. GGACCCTGGTGACTACGAGA 137 bp [GenBank:
NM_024354]
rev. CATAGAACAGGTGGGCCTTG
nAChR
a5
for. TGGAACACCTGAGCGACAAG 284 bp [GenBank:
NM_017078]
rev. CGTGACAGTGCCGTTGTACC
nAChR
a6
for. TGGTGTTAAGGACCCCAAAA 142 bp [GenBank:
NM_057184]
rev. GCTGCTGGCTTAACCTCTTG
nAChR
a7
for. ACATTGACGTTCGCTGGTTC 235 bp [GenBank:
L31619]
rev. CTACGGCGCATGGTTACTGT
nAChR
a9
for. CGTGGGATCGAGACCAGTAT 142 bp [GenBank:
AY574257]
rev. TCATATCGCAGCACCACATT
nAChR
a10
for. GTGCCACTCATCGGAAAGTA 107 bp [GenBank:
NM_022639]
rev. TGTGCATTAGGGCCACAGTA
nAChR
b1
for. TCCTAAGCGTGGTGGTCCTC 151 bp [GenBank:
NM_01258]
rev. TGTGGTTCGGGTAGTTGGTC
nAChR
b2
for. AGCCTTCTTTGGCTGTGCTC 116 bp [GenBank:
NM_019297]
rev. GAGCCGTTAGTAGCTGGACGA
nAChR
b3
for. CACTCTGCGCTTGAAAGGAA 196 bp [GenBank:
NM_133597]
rev. GCGGACCCATTTCTGGTAAC
nAChR
b4
for. CACTCGCGGTTCCATTGTAG 159 bp [GenBank:
NM_052806]
rev. CGGGTTTTGTTCAGGAGGTC
P2Y1 for. AGGAAAGCTTCCAGGAGGAG 203 bp [GenBank:
NM_012800]
rev. GGCCAATAGAATGTTGCTTCTT
P2Y2 for. CATGCGAGTGAAGAACTGGA 209 bp [GenBank:
NM_017255]
rev. GGCAGCAGCACATACTTGAA
P2Y4 for. AGTCCCTGGGCTGGACTAAG 267 bp [GenBank:
NM_031680]
rev. GTGTCTGACAATGCCAGGTG
HPRT1 for. TCCCAGCGTCGTGATTAGTG 225 bp [GenBank:
NM_012583]
rev. TCCAGCAGGTCAGCAAAGAA
Sequences for forward (for.) and reverse (rev.) primers are given in 5’®3’
order.
Table 2 Mouse primer sequences used in the study
Target Sequence Length Accession No.
nAChR
a7
for ACAATACTTCGCCAGCACCA 144 bp [GenBank:
AF225980]
rev AAACCATGCACACCAGTTCA
nAChR
a9
for CAATGCTCTGCGTCCAGTAG 209 bp [GenBank:
XM_132045]
rev ACACCAGATCGCTGGGAATC
nAChR
a10
for TCTGCTCCTGCTCTTTCTCC 208 bp [GenBank:
XM_89067]
rev CCACAGGTACAAGGTCAGCA
nAChR
b2
for GAGTGTGAGGGAGGATTGGA 139 bp [GenBank:
AY574268]
rev TCGTGGCAGTGTAGTTCTGG
nAChR
b4
for CAGCCCATCCAACCTCTATG 156 bp [GenBank:
NM_148944]
rev CTGACGCCCTCTAATGCTTC
b-MG for ACCCTGGTCTTTCTGGTGCT 150 bp [GenBank:
NM_009735]
rev AATGTGAGGCGGGTGGAA
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and application of secondary antibody for 1 h. Slides
were washed, fixed in buffered 4% paraformaldehyde,
coverslipped in carbonate-buffered glycerol (pH 8.6) and
examined with a Zeiss Axioplan 2 microscope (Zeiss,
Jena, Germany) and sequential confocal laser scanning
microscope (CLSM, TCS SP2, Leica, Bensheim,
Germany) using argon and HeNe lasers equipped with
appropriate filter sets. Secondary antisera were
Cy3-coupled donkey anti-rabbit IgG (1:2000 in PBS,
Chemicon, Hofheim, Germany), Cy3-coupled donkey
anti-guinea pig IgG (1:800 in PBS, Dianova, Hamburg,
Germany), fluorescein-isothiocyanate-conjugated donkey
anti-mouse Ig (1:400, Dianova), and Texas Red®-conju-
gated donkey anti-guinea pig Ig (1:100, Dianova).
Positive controls were run on shock-frozen and acetone-
fixed DRG sections. The specificity of the immunolabel-
ing was validated by omission of the primary antibody
or preincubation with the corresponding antigen. Preab-
sorption was done by mixing antibodies with peptide
used for immunization (14-24 μg of peptide per 100 μl
of antibody solution) for 1 h before application on
slides. Peptides were obtained from the same source as
the antibodies (Table. 3).
SDS-PAGE and immunoblotting
nAChR a7 and a10 subunits detection
Snap-frozen rat BAL cells, rat brain and skin samples
were homogenized and boiled in Laemmli’s sample buf-
fer [16] containing Complete® protease inhibitor cocktail
(Roche, Mannheim, Germany). SDS-PAGE was carried
out using 15% polyacrylamide gels according to Laemmli
et al. [16]. Samples (5 × 104 cells) and Rainbow™ colored
molecular mass markers (Amersham Pharmacia Biotech,
Freiburg, Germany) were separated on the same gel.
Proteins were transferred electrophoretically onto
Immobilon™-P PVDF membranes (Millipore, Bedford,
USA) using a blotting buffer consisting of 25 mM Tris,
192 mM glycine, 20% methanol and 0.05% SDS. Mem-
branes were pre-incubated with PBS containing 10%
Rotiblock (Roth, Karlsruhe, Germany) solution for 1 h.
Primary mouse-anti-nAChR a7 (1:1000, Sigma-Aldrich,
Taufkirchen, Germany) antibodies were diluted in block-
ing solution and incubated with membranes overnight at
4°C. For the detection of a10 subunits, membranes were
pre-incubated with PBS containing 5% non-fat milk
powder (Roth) and guinea pig-anti-nAChR a10 (1:4000,
[17]) antibodies were used. Blots were washed in PBS,
0.05% Tween 20 and bound primary antibodies were
detected by horseradish peroxidase-conjugated immuno-
globulins (DAKO, Hamburg, Germany) in PBS, 2% low
fat milk, 0.05% Tween 20 (TPBS). Secondary antisera
were rabbit anti-mouse IgG (1:5000 in TPBS + 1% nor-
mal rat serum) and rabbit-anti-guinea pig IgG (1:5000
in TPBS + 2% low fat milk). Peroxidase activity was
visualized by SuperSignal® West Pico Chemiluminescent
Substrate (Pierce, Rockford, IL, USA) using the Kodak
Scientific Imaging Film X-OMAT™ LS (Eastman Kodak,
Rochester, NY, USA). Gels and blots were documented
and densitometrically analyzed using a digital gel
documentation system (Biozym, Hessisch Oldendorf,
Germany).
STAT3 phosphorylation
Lavaged rat cells were plated on a 24 well plate (Becton
Dickinson, USA) at 3.5 × 105 cells/well in RPMI 1640
Table 3 Antibodies used in the study
Target Immunogen Host Dilution Source
nAChR a3 Synthetic peptide (aa 466-474 of human sequence)a Rabbit 1:1600 Acris
nAChR a4 Synthetic peptide (620-627, human)a Rabbit 1:800 Acris
nAChR a5 Synthetic peptide (460-468, human)a Rabbit 1:1600 Acris
nAChR a7 Synthetic peptide (493-502, human)a Rabbit 1:1000 Acris
nAChR a7 Native and denatured a7 subunit (380-400, chicken) and denatured a7
subunit from rat
Mouse, monoclonal, clone
mAb 306
1:750 Sigma-
Aldrich
nAChR a9 Synthetic peptides (81-97 and 115-128, rat) Guinea-pig 1:1000 [44]
nAChR a10 Synthetic peptide (404-418, rat)a Rabbit 1:2000 [17]
nAChR b2 Synthetic peptide (493-502, human)a Rabbit 1:1600 Acris
nAChR b3 Synthetic peptide (450-458, human)a Rabbit 1:800 Acris
nAChR b4 Synthetic peptide (490-498, human)a Rabbit 1:3200 Acris
CD68-like Rat spleen cells Mouse, monoclonal, clone ED1 1:800 Serotec
pSTAT3
Tyr705
Synthetic phospho-peptide residues surrounding Tyr705 of mouse Stat3 Rabbit, monoclonal, clone
D3A7
1:1000 Cell
Signaling
pSTAT3
Ser727
Synthetic phospho-peptide residues surrounding Ser727 of mouse Stat3 Rabbit, monoclonal 1:1000 Cell
Signaling
STAT3 Synthetic peptide corresponding to the sequence of mouse Stat3 Rabbit, monoclonal 1:1000 Cell
Signaling
Origin and regions of nAChR subunits sequences used for generation of the antibodies are provided in brackets. aPeptides available for preabsorption.
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medium supplemented with L-glutamine, penicillin (100
U/ml) and streptomycin (0.1 mg/ml). Cells were allowed
to attach for 2 h and subsequently were stimulated with
nicotine (Sigma-Aldrich) at 10-4 M, 10-5 M, and 10-6 M
or GM-CSF (R&D Systems, Minneapolis, MN) at 100
ng/ml for indicated time intervals. Cells were washed
twice with cold PBS and lysed with lysis buffer contain-
ing 20 mM Tris (pH 7.5), 150 mM NaCl, 1 mM EDTA
(pH 8.0), 1 mM EGTA (pH 8.0), 0.5% NP-40, 2 mM
sodium orthovanadate (pH 10.0), and Complete® pro-
tease inhibitor cocktail (Roche). The lysates were kept
on ice for 30 min, followed by centrifugation for 15 min
at 13,000 rpm at 4°C, and subsequent protein concen-
tration measurement was assessed by Bradford Assay as
suggested by the manufacturer (Bio-Rad). Proteins were
loaded on a gel in a total amount of 10 μg, separated by
electrophoresis on 10% SDS-PAGE, and transferred to
polyvinylidene difluoride membranes (Amersham GE
Healthcare, Little Chalfont, Buckinghamshire, UK).
Membranes were incubated in blocking buffer (5% non-
fat milk in PBS, 0.05% Tween 20) at room temperature
for 1 h, and then overnight at 4°C with primary antibo-
dies recognizing total and phosphorylated STAT3
(1:1000, Cell Signaling Technology, Beverly, MA). Blots
were washed three times for 15 min, and incubated with
horseradish peroxidase-conjugated anti-rabbit IgG
(1:3500, Pierce, Rockford, IL). Enhanced chemilumines-
cence system was used to visualize immune complexes
(Amersham GE Healthcare, Little Chalfont, Buckin-
ghamshire, UK).
Electrophysiological recording
For whole cell patch-clamp recordings, 200 μl cell sus-
pension obtained from rat BAL was placed in recording
dishes (Nunc, Roskilde, Denmark), incubated for 1-3 h
at 37°C and 5% CO2 in DMEM/F12 medium to allow
the cells to attach. PC12 cells (rat adrenal pheochromo-
cytoma cells) were obtained from German Collection of
Microorganisms and Cell Cultures (Braunschweig,
Germany) and maintained at 37°C and 5% CO2 in RPMI
1640 medium supplemented with 10% horse serum
(PAA), 5% FCS, 2 mM L-glutamine, penicillin (100 U/
ml), streptomycin (0.1 mg/ml) and used as described
above.
For recordings, the medium was carefully removed,
cells were washed 2-3 times, covered with bath solution
containing (in mM): NaCl 120, KCl 5.4, CaCl2 2, MgCl2
1, Hepes 10, D-glucose 25, pH 7.5, and the dish was
placed under a microscope (Axiovert, Göttingen,
Germany).
Borosilicate glass capillaries (Hilgenberg, Malsfeld,
Germany) with an outer diameter of 1.6 mm were
pulled to recording pipettes by a vertical puller (Nar-
ishige, Tokyo, Japan). The tips of the pipettes were fire-
polished using a microforge (List-Medical, Darmstadt,
Germany) and had resistances between 5-10 MΩ when
filled with the pipette solution containing (in mM): KCl
120, CaCl2 1, MgCl2 2, Hepes 10, EGTA 11, D-glucose
20, pH 7.3. The junction potential under these condi-
tions (bath and pipette solution) was 3.4 mV although
the membrane voltage was not corrected with respect to
this junction potential.
The whole cell configuration was mainly obtained by
suction and in some cases voltage pulse was additionally
applied. Transmembrane currents were recorded at
holding potentials of -60 mV in the absence of, as well
as after ACh application into the bath. The agonist was
applied via a pipette to the bath to reach a final concen-
tration of 100 μM. In some experiments, a VM-4
micro-perfusion system was used for drug compound
application (ALA Scientific Instruments, Westbury,
USA). The measured signals were amplified by an EPC-
9 patch-clamp amplifier (HEKA, Lambrecht/Pfalz,
Germany), which was connected via an ITC-16 interface
to a personal computer. For continuous recordings, the
signals were filtered with 300 Hz and acquired at 3 kHz
using the Pulse 8.77 software (HEKA). Current/voltage
relationships signals were filtered with 3.33 kHz and
acquired at 10 kHz. Data ware analyzed and prepared
using PulseFit (HEKA) and Igor (Wavemetrics, Lake
Oswego, USA). All recordings were performed at room
temperature.
Intracellular calcium concentration measurements
Recordings of [Ca2+]i were performed after 3-8 h in pri-
mary culture (n = 3 animals and 10-12 coverslips for
each experimental setup). Measurements were done in
Hepes buffer containing (in mM): KCl 5.6, NaCl 136.4,
MgCl2 1, CaCl2 2.2, D-glucose 11, Hepes 10. In some
experiments, CaCl2 was omitted from the buffer compo-
sition. Cells were loaded for 30 min with 3.3 μM fura-2
AM (Invitrogen) and washed 3 × 10 min. Fura-2 was
excited at 340 and 380 nm wavelengths (l), and fluores-
cence was collected at l > 420 nm. The fluorescence
intensity ratio of 340/380 nm was recorded. Cells were
exposed to nicotine (10-6-10-4 M, Sigma-Aldrich) or epi-
batidine (10-6 M, Sigma-Aldrich). Controls were per-
formed with vehicle treatment. Two min after
administration of nicotine or epibatidine, cells were sti-
mulated with ATP (10-4 M, Sigma-Aldrich). In some
experiments cells were exposed to nicotine in the pre-
sence of the nAChR a7 and a9/a10 blocker a-bungaro-
toxin (10-7 M, Sigma-Aldrich). Cells that did not
respond to ATP by at least 5% change in [Ca2+]i were
excluded from further analysis. Viability of the cells was
monitored after measurements with Trypan Blue exclu-
sion. Ratio values were normalized to 100% at the begin-
ning of recording. Curves were plotted from recordings
Mikulski et al. Respiratory Research 2010, 11:133
http://respiratory-research.com/content/11/1/133
Page 5 of 16
done in preparations from n = 3 animals. Data are
shown as mean ± SEM.
Statistical analysis
Data in the figures and text are expressed as mean ±
SEM. Non-parametric rank based Kruskal-Wallis test
was used to compare multiple groups, and if significant
differences were detected, it was followed by Mann-
Whitney test to compare between two experimental
groups. Tests were performed using SPSS software
(SPSS software, Munich, Germany). P ≤ 0.05 was con-
sidered significant and P ≤ 0.01 as highly significant.
Results
Rat alveolar macrophages constitutively express nAChR
subunits a9, a10 and b2, but not a7
RT-PCR analysis of mRNA isolated from rat BAL cells
revealed expression of nAChR subunits a2, a3, a5, a9,
a10, b1, and b2. Products corresponding to the a4, a6,
a7, and b3 subunits were never found in BAL cells (Fig.
1), although they were easily detectable in DRG and
lung homogenate (a7 and b3 subunits). The mRNAs of
subunits a9, a10, b1, and b2 were consistently
expressed. Subunits a2, a3, and b4 were detected in 1
out of 9 preparations. Subunit a5 was present in 3 out
of 9 preparations. The identity of amplified products
was confirmed by sequencing, and control runs without
template were negative.
In indirect double-labeling immunofluorescence, the
vast majority of rat BAL cells showed strong staining
with ED1 antibody, an AM marker. ED1-positive cells
were immunoreactive for a9, a10, and b2 nAChR subu-
nits, and in 50% of BAL preparations (5 out of 10 sam-
ples) for the a5 subunit as well. Preabsorption with the
synthetic peptides used for immunization resulted in
absence of immunolabeling (Fig. 2). Staining was predo-
minantly intracellular, localized near the nucleus, except
for a5 and a9 subunit-immunoreactivity that exhibited a
punctate surface distribution in a subset of AM (Fig. 2,
inserts). The rabbit polyclonal antibody to a7 subunit
faintly stained AM, but preabsorption with correspond-
ing peptide gave the same staining pattern. The monoclo-
nal antibody to the a7 nAChR subunit (mAb 306) did
not show any labeling of AM. Positive controls were run
on DRG sections, demonstrating labeling of neuronal cell
bodies with mAb 306 (Fig. 3). There was no specific
labeling for subunits a3, a4, b3, and b4 in ED1-positive
cells (Fig. 2 and data not shown). Similar staining pat-
terns with antisera directed against nAChR subunits were
observed in rat lung sections (Fig. 3). Here, the antiserum
against the a9 nAChR subunit showed marked punctuate
membrane staining of AM (Fig. 3, insert).
Figure 1 RT-PCR analysis of nAChR subunits in BAL cells, which consistently express mRNA coding for a9, a10, b1 and b2 subunits.
Subunit a5 shows an interindividual expression pattern. The mRNAs coding for a1, a4, a6, a7 and b3 subunits are absent. Positive controls
were run on DRG (a2-a10), lung (b2-4), and skeletal muscle (a1 and b1). Negative controls were done without RT.
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Western blotting supported the immunohistochemical
findings in that the mAb 306 failed to detect the a7
subunit in protein preparations from rat BAL cells while
it recognized a ~50 kDa band in protein extracts from
rat brain (Fig. 4). In Western blots of rat skin homoge-
nates serving as a positive control, a single 67-kDa pro-
tein was recognized utilizing a previously characterized
antiserum directed against the a10 nAChR subunit [12].
As shown in Fig. 4, this band plus additional bands at
110-130 kDa were immunolabeled in protein prepara-
tions from BAL cells.
Acetylcholine has no effect on AM cell membrane
conductivity
Recordings were performed at -60 mV holding potential.
ATP (2 × 10-4 M) induced currents in approximately
50% of the recorded rat AM (Fig. 5A). Notably, no
changes in membrane currents were detected when
ACh (10-4 M) was added to the bath (Fig. 5D, n = 15).
In a separate set of recordings, ACh was applied via a
perfusion system, again without triggering changes in
transmembrane current (IM) (see insert of figure 5D). In
contrast, PC12 cells readily responded to ACh applica-
tion by an increased inward current (Fig. 5C).
For further characterization of AM responses, I/V
curves were recorded by applying voltage steps of 20
mV from -100 to 100 mV, starting from a holding
potential of -60 mV. I/V-relationships were also
recorded in the absence (Fig. 5F) and presence of ACh
(Fig. 5E). Again, no changes of IM were evoked by ACh
application.
ATP-triggered increase in calcium derives from
intracellular stores
In freshly isolated rat AM, ATP (10-4 M) induced a
rapid rise in [Ca2+]i followed by a slow decrease.
Figure 2 Double-labeling immunofluorescence demonstrating the presence of the nAChR subunits a5, a9, a10 and b2 in ED1-positive
BAL cells. A punctate fluorescence pattern for the a5 and a9 nAChR subunits was found in a subset of AM (inserts). Negative results were
noted for a3 and a7 subunits in ED1-positive cells, despite occasional occurrence of a3 subunit immunoreactive ED1-negative cells (arrow). Bar:
20 μm, 10 μm in inserts.
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Exclusion of calcium ions from the external solution had
no effect on the amplitude of the ATP-induced initial
[Ca2+]i rise (46% for +Ca
2+ and 47% for -Ca2+ Hepes
buffer). Macrophages exposed to extracellular Ca2+
showed a sustained increase in [Ca2+]i whereas cells sti-
mulated in Ca2+-free buffer showed only a transient rise
without reaching a plateau phase (P ≤ 0.001) (Fig. 5A).
The percentage of cells reacting to the ATP stimulus
Figure 3 Immunohistochemistry on rat lung sections and DRG (positive control). The mAb 306 directed against the a7 subunit fails to
label AM (arrow) but it stains nerve cell bodies (arrows) in DRG sections serving as a positive control. Arrowheads: Elastin autofluorescence in
alveolus. The antibodies to a9 and a10 subunits label ED1-positive AM in alveoli. The insert demonstrates punctate a9 subunit immunoreactivity
in a CLSM optical section. AS = alveolar septum. Bar: 20 μm.
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was decreased from 58% in calcium-containing to 18%
in calcium-free buffer (582/1012 cells in +Ca2+ vs 197/
1085 cells in -Ca2+ buffer). To better understand which
receptors might be involved in ATP-induced [Ca2+]i rise
we performed RT-PCR analysis and found P2Y1, P2Y2
and P2Y4 purinergic receptor mRNAs in AM (Fig. 6B).
Nicotine modulates ATP-induced rise in intracellular [Ca2+]
We tested whether nicotine modulates [Ca2+]i levels.
Half of the macrophage population (131/261 cells)
exposed to ATP showed a transient rise in [Ca2+]i
(increase by 47%). Application of nicotine (10-6, 10-5,
10-4 M) or epibatidine (10-6 M) had no direct effect on
[Ca2+]i. Nicotine given 2 min prior to ATP reduced the
ATP-induced calcium peak by 38% (P ≤ 0.006), while
not changing the percentage of cells reacting to the
ATP stimulus (54%, 120/222 cells). Epibatidine was
neither effective in reducing ATP-induced transients nor
it changed the percentage of cells reacting to the ATP
(51%, 117/230 cells) (Fig. 7A).
In a separate set of experiments, we tested if the
effect of nicotine can be blocked with the a1, a7 and
a9/a9a10 nAChR antagonist a-bungarotoxin. This
drug alone (10-7 M) had no effect on ATP-induced
calcium increase, when compared to vehicle control,
but it abrogated the effects of nicotine (P ≤ 0.001).
The transient rise in [Ca2+]i in cells treated with a-
bungarotoxin together with nicotine was slightly
increased compared to vehicle-treated cells (P ≤ 0.025)
(Fig. 7B).
We used AM isolated from a7 nAChR-deficient mice
to determine the role of this subunit in cholinergic
modulation of ATP-induced Ca2+ response. Cells iso-
lated by BAL from C57BL6N mice expressed mRNAs
corresponding to a9, b2 and b4 nAChR subunits (Fig.
8A). Messenger RNA for the a10 subunit was found in
3 out of 5 samples, while a7 nAChR subunit mRNA
was never detected in BAL cells. Pretreatment with
nicotine significantly attenuated the transient rise in
[Ca2+]i triggered by ATP in BAL cells isolated from
C57BL6N and a7 nAChR-deficient mice (Fig. 8B), albeit
the reduction was much less pronounced than in rat
cells.
Nicotinic modulation is not dependent on extracellular
calcium
Next we tested if the nicotine-mediated effect upon the
ATP-induced [Ca2+]i rise is depended on extracellular
calcium. Rat cells treated with nicotine (10-4 M) 2 min
before the ATP stimulus showed a decreased amplitude
of the ATP-induced rise in [Ca2+]i. This was not affected
by the absence of Ca2+ in the external bath solution
(Fig. 7B). The number of cells reacting to ATP was
reduced when Ca2+ was omitted in the external solution
(18% for vehicle and 16% for nicotine treated cells) com-
pared to Ca2+-supplemented medium (42% for vehicle
and 39% for nicotine treated cells).
Nicotine does not induce STAT-3 phosphorylation
To test whether nicotinic stimulation of BAL cells trig-
gers STAT-3 phosphorylation, as it has been reported
for peritoneal macrophages [3], Western blot analysis
was performed. Rat BAL cells were exposed to 10-4,
10-5, and 10-6 M nicotine or to 100 ng/ml GM-CSF ser-
ving as a positive control. No visible STAT-3 phosphor-
ylation on Tyr705 epitope was observed in nicotine
treated samples 5, 15, 30 and 60 min after stimulation.
Similar results were obtained with an antibody recogniz-
ing phosphorylation of Ser727 epitope (data not shown).
In contrast to nicotine, GM-CSF caused profound
STAT-3 phosphorylation as soon as 5 min after addition
to the cells (Fig. 9).
Figure 4 Immunoblots. No a7 subunit-immunolabeling is present
in BAL samples, while the antibody mAb 306 recognizes a single 50
kDa protein band in protein extracts from rat brain. Affinity purified
polyclonal antibodies to a10 nAChR label a protein band at 67 kDa
in BAL cells and rat skin samples. In BAL cells, additional bands at
110-120 kDa are immunolabeled.
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Discussion
This study is the first to demonstrate acute receptor-
dependent, modulatory effects of nicotine on AM. The
nAChR involved in this process differ from subtypes
reported previously to be involved in “cholinergic anti-
inflammatory pathways” outside the lung. Although the
effects of nicotine are receptor mediated, these receptors
do not form a classical ion channel known from neuro-
nal cells.
Importantly, we detected neither mRNA nor protein
of a7 nAChR in AM in contrast to easily detectable a7
subunit mRNA in sensory neurons, brain and in the
whole lung homogenate. This is consistent with
reported data on the lack of the expression of a7
nAChR in the murine AM cell line MH-S [18] and our
previous work on expression of nAChR in freshly iso-
lated murine AM [19]. In contrast, binding of the poly-
clonal nAChR a7 antibody H-320 to murine AM has
Figure 5 Patch clamp recordings on AM (A, B, D-F) and on PC12 cells (C). (A) Representative whole cell recording depicting the measured
membrane current (IM) at -60 mV in absence of and following ATP application (2 × 10
-4 M, indicated by arrow). Agonist was applied directly to
the bath via a pipette. ATP activates transient inward currents. (B) Control recording where bath solution was applied instead of agonist. (C)
Effect of ACh (10-4 M) on PC12 cells. ACh induces strong inward currents. (D) Application of ACh to the bath solution has no effect on
membrane currents in AM. Insert: The use of a perfusion system also did not induce any significant changes of the membrane current in
response to ACh. (E, F) Current-voltage relationship recorded in the absence of (control, E) and immediately after ACh application (F). In these
recordings, again no changes in membrane current were detected.
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been reported by Su et al. [8,9] and was also noted by
our group in a previous study in the absence of a7 sub-
unit mRNA detection [19]. This antibody, however, pro-
duces identical staining in immunohistochemistry and
western blotting of the mouse brain, clearly demonstrat-
ing lack of specificity at least in the nervous system [20],
so that these findings have to be considered with
caution unless corresponding controls on mouse
lungs from a7 nAChR-/- mice have been successfully
performed.
Still, there might be species differences and plasticity
in receptor expression under pathological conditions,
since a low level of basal expression of a7 nAChR
subunit mRNA in AM isolated from healthy volunteers
and an increase in AM isolated from smokers has been
reported [21]. Also, a7 nAChR are essential for systemic
cholinergic anti-inflammation since the beneficial effects
of nicotine in endotoxemia are abrogated in a7 subunit
gene-deficient mice [2]. Accordingly, two potent a7
nAChR agonists, GTS-21 and PNU-282987 [22,23], inhi-
bit LPS-induced TNFa release and reduce acid-induced
acute lung injury, respectively, in the mouse lung [8,10].
Their potency on the most prevalent nAChR subunits
identified in our present study on AM, i.e. a9 and a10
nAChR that generally share many pharmacological
properties with a7 nAChR [24], yet has not been
Figure 6 Purinergic receptors on freshly isolated BAL cells. ATP-induced transients in [Ca2+]i are mainly dependent on intracellular stores. (A)
BAL cells were stimulated with ATP (10-4 M) in the presence or absence of extracellular Ca2+. Sustained increase, but not initial rise in [Ca2+]i is
dependent on extracellular Ca2+. Number of cells which reacted, and total number of measured cells are given in brackets. n.s. = not significant,
***P ≤ 0.001. (B) RT-PCR in rat BAL cells shows expression of P2Y1, P2Y2 and P2Y4 purinergic receptors.
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determined. Without doubt, however, a7 nAChR is
expressed in the lung as demonstrated by RT-PCR in
this and previous studies [25,26]. Functional data show
increases in acid-induced excess lung water and vascular
permeability in a7 nAChR deficient mice [8]. Endothe-
lial cells may account for this effect [27]. However, since
all a7 nAChR antibodies tested so far produce immuno-
histochemical labeling also in organs taken from a7
nAChR deficient mice [20,28], immunohistochemistry
alone cannot decipher the cell-type specific a7-subunit
distribution in the lung, and this issue remains to be
solved.
Instead of a7 we observed expression of nAChR subu-
nits a9, a10, b1, and b2, and to a variable extent a2,
a3, a5, in rat AM. Mouse AM expressed nAChR subu-
nits a9, a10, b2, and b4. To form classical, ion-conduct-
ing nAChR, a subunits combine as heteropentamers
with b subunits or build a heteropentamers of a9a10
and homopentamers of a7 and a9 (for review, see [29]).
The subunits detected in AM in the present study
would allow combining the following nAChR pentamers:
a3b2, a3a5b2, a9a10, and a9 as homopentamer. Since
there is a constant expression of subunits a9 and a10 in
AM, this combination as homo- or heteropentamer
seems to be most likely, if pentamer formation occurs at
all.
These subunits have been best characterized in the
inner ear, where they form Ca2+-permeable ion channels
involved in efferent modulation of hair cell function
[30,31]. Our whole-cell patch clamp recordings and
[Ca2+]i measurements in rat AM, however, neither
revealed changes in membrane current in response to
ACh nor in [Ca2+]i in response to nicotine. Similarly, a
subpopulation of human T-lymphocytes expresses a9
and a10 nAChR subunits but fails to show transmem-
brane currents triggered by ACh [5], and nicotine does
not cause alteration of [Ca2+]i in the rat AM cell line
NR8383 [32] and in rat intravascular mononuclear leu-
kocytes obtained from isogenic kidney transplants [7].
Thus, a9a10 nAChR subunits apparently do not form
classical ionotropic receptors in cells of the immune sys-
tem. Still, a9a10 nAChR subunits confer intracellular
effects as our data demonstrate an acute a-bungarotoxin
sensitive modulatory effect of nicotine upon ATP-
induced calcium release from intracellular stores. In
general, although to a much smaller extent than in rat
cells, this effect was also present in macrophages iso-
lated from C57BL6N and a7 nAChR subunit deficient
mice, demonstrating its independency from the a7
nAChR subunit. Similarly, we recently identified a
methyllycaconitine sensitive modulatory effect of nico-
tine upon ATP-induced rise in [Ca2+]i in rat mononuc-
lear leukocytes obtained by vascular perfusion of
Figure 7 Nicotine dampens ATP-induced increase in [Ca2+]i. (A)
BAL cells were stimulated with ATP (10-4 M) in the presence or
absence of nicotine (10-4 M) or epibatidine (10-6 M). * P ≤ 0.01
(nicotine compared to Hepes) (B) The nicotine-induced effect is
blocked by pre-incubation with the nicotinic antagonist
a-bungarotoxin (10-7 M). ***P ≤ 0.001 (nicotine compared to
a-bungarotoxin + nicotine) #P ≤ 0.05 (Hepes compared to
a-bungarotoxin + nicotine). (C) Nicotine-mediated effect on ATP-
induced [Ca2+]i rise is not depended on extracellular calcium. BAL
cells were treated with nicotine (10-4 M) or with the vehicle in the
presence of extracellular Ca2+. Immediately before measurements,
cells were transferred to Ca2+-free buffer where a constant leakage
of Ca2+ from the cells can be observed. BAL cells were pre-treated
with nicotine or with the vehicle, and then stimulated with ATP
(10-4 M). Number of cells which reacted, and total number of
measured cells are given in brackets. ***P ≤ 0.001, *P ≤ 0.05.
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isogenic kidney transplants [7]. In line with this observa-
tion, a9 subunit containing nAChR in outer hair cells of
the inner ear do not exclusively assemble into ionotropic
receptors, but form metabotropic receptors as well.
Here, ACh also reduces ATP-induced rise in [Ca2+]i at a
concentration that alone is insufficient to impact [Ca2+]i,
and again this effect is a-bungarotoxin sensitive [33].
Atypical, non-ionotropic effects have also been
reported for the nAChR a7 subunit. In T cells, this sub-
unit fails to form a ligand-gated Ca2+ channel but inter-
acts with CD3ζ to modulate TCR/CD3 function [6].
Notably, a7 subunits in this complex exhibit a different
agonist/antagonists profile than neuronal ionotropic a7
nAChR. Methyllycaconitine and a-bungarotoxin, both
potent inhibitors of ionotropic a7 nAChR, indeed are
strong agonists at T cells expressing nAChR a7 subunits
[6]. Correspondingly, epibatidine, a highly potent agonist
at ionotropic nAChR, failed to mimic the nicotine effect
in our present experiments on rat AM.
In contrast to the well-characterized channel proper-
ties of nAChR, the mechanisms of atypical nAChR sig-
naling are currently only poorly understood. In
peritoneal macrophages, coupling of a7 nAChR to the
Jak2-STAT3 signaling pathway resulting in STAT3
phosphorylation has been reported [3] which we could
not observe in rat AM predominantly expressing a9 and
a10 subunits. Membrane bound nAChR subunits have
been demonstrated to interact with and to modulate sig-
naling by b-arrestin [34], phosphatidyl-inositol-3-kinase
[35], CD3ζ [6], and purinergic P2X-receptors [36,37].
The latter are involved in ATP-induced increase in [Ca2
+]i by extracellular influx in human AM, since initial
Ca2+ transients are reduced by 40% in Ca2+-free med-
ium [38]. In our present study of rat AM, however, the
Figure 8 Nicotinic receptors on mouse BAL cells. (A) RT-PCR, agarose gel electrophoresis. Mouse BAL cells consistently express mRNAs coding
for a9, b2 and b4 subunits. Subunit a10 shows an interindividual expression pattern. The mRNA for a7 subunit was not found in BAL
preparations, although it was easily detectable in brain homogenate, serving as a positive control. M = DNA marker, H2O = water control (B)
Ratiometric [Ca2+]i recordings. Mouse BAL cells isolated from C57BL6N, a7 nAChR knockout (a7
-/-) and littermate control animals (a7+/+) were
stimulated with ATP (10-4 M) in the presence or absence (Hepes) of nicotine (10-4 M). Peak increases shown as mean ± SEM; cells taken from 6-9
coverslips for each experimental setup, p-values calculated by Mann-Whitney test.
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ATP-induced initial increase in [Ca2+]i and the modula-
tory effect of nicotine persisted in Ca2+-free solution,
demonstrating interference of atypical nAChR with P2Y-
receptor mediated Ca2+-release from intracellular stores.
In support, we observed expression of P2Y purinergic
receptors on AM, among them P2Y2 that mediates
Ca2+-release from the endoplasmatic reticulum in
mouse macrophages [11].
Extracellular ATP is well recognized as a “danger” or
“host tissue damage” signal and is mostly regarded to
promote inflammation [39,40]. In human AM, it couples
to [Ca2+]i increases and stimulates IL-1b and IL-6 release
albeit suppressing TNFa production [38]. In the rat AM
cell line NR8383, ATP induces P2Y2- and Ca
2+-depen-
dent increase in CCL2 synthesis and release [41]. The
CCL2-CCR2 axis is a crucial regulator of inflammatory
cell influx into the murine lung [42,43]. Hence, the pre-
sently observed nicotinic attenuation of ATP-induced
rise in [Ca2+]i can be considered as an anti-inflammatory
mechanism triggered by atypical nAChR.
Conclusions
Rat AM are equipped with modulatory nAChR with
properties distinct from ionotropic nAChR mediating
synaptic transmission in the nervous system. Their sti-
mulation with nicotine dampens ATP-induced Ca2
+-release from intracellular stores. Thus, the present
study identifies the first acute receptor-mediated but
atypical nicotinic effect on AM with anti-inflammatory
potential.
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